Condition
Anger Problems
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (5)
Trial Status
Completed2
Not Yet Recruiting2
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07661823Not ApplicableNot Yet Recruiting
QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428
NCT06609330Not ApplicableRecruitingPrimary
Treatment of Chronic Anger and Aggression Following Military-Related Betrayal
NCT06827015Not ApplicableCompletedPrimary
Laughter Yoga's Impact on Children's Anger and Well-Being
NCT07203170Not ApplicableNot Yet Recruiting
Evaluation of the Readiness Supportive Leadership Training - National Guard
NCT02157779Not ApplicableCompletedPrimary
Treatment of Trauma-Related Anger in OEF/OIF/OND Veterans
Showing all 5 trials